[1]史鲁斌△,吕宛玉,王 燕,等.2011年至2016年河南省乙型脑炎减毒活疫苗预防接种不良反应监测*[J].郑州大学学报(医学版),2017,(06):757-761.[doi:10.13705/j.issn.1671-6825.2017.06.023]
　SHI Lubin,LYU Wanyu,WANG Yan,et al.Surveillance data of adverse reactions for live attenuated Japanese encephalitis vaccine in Henan Province from 2011 to 2016[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2017,(06):757-761.[doi:10.13705/j.issn.1671-6825.2017.06.023]
点击复制

2011年至2016年河南省乙型脑炎减毒活疫苗预防接种不良反应监测*()
分享到：

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2017年06期
页码:
757-761
栏目:
应用研究
出版日期:
2017-11-15

文章信息/Info

Title:
Surveillance data of adverse reactions for live attenuated Japanese encephalitis vaccine in Henan Province from 2011 to 2016
作者:
史鲁斌△; 吕宛玉; 王 燕; 姬艳芳; 李 军; 于 燕; 叶 莹; 张延炀
河南省疾病预防控制中心免疫预防与规划所 郑州 450016
Author(s):
SHI Lubin;  LYU Wanyu; WANG Yan; JI Yanfang; LI Jun; YU Yan; YE Ying; ZHANG Yanyang
Immune Planning Division,Henan Center for Disease Control and Prevention,Zhengzhou 450016
关键词:
乙型脑炎减毒活疫苗;  预防接种不良反应;  监测;  河南省
Keywords:
live attenuated Japanese encephalitis vaccine;  adverse reactions;  surveillance;  Henan Province
分类号:
R186+.3
DOI:
10.13705/j.issn.1671-6825.2017.06.023
摘要:
目的:分析2011年至2016年河南省乙型脑炎减毒活疫苗(JEV-L)预防接种不良反应的流行病学特征,评价JEV-L预防接种的安全性。方法:通过中国免疫规划信息管理系统,收集2011年至2016年河南省报告的JEV-L预防接种不良反应个案数据和JEV-L预防接种数据,采用描述流行病学方法进行分析。结果:2011年至2016年河南省共报告JEV-L预防接种不良反应5 236例,年平均报告发病率为25.74/10万剂。5 236例不良反应中,一般反应5 126例,占97.90%,报告发生率为25.20/10万剂; 异常反应110例,占2.10%,报告发生率为0.54/10万剂。不良反应男女性别比为1.22GA6FA1; <1岁者占60.06%; 7～9月份不良反应报告最多,占32.75%; 报告病例主要集中在洛阳市、郑州市和周口市等地。不良反应主要发生在第1剂次接种后和接种后<1 d。一般反应临床诊断均为发热、红肿、硬结,异常反应以过敏反应性疾病为主,有过敏性休克和脑炎病例报告。所有不良反应中,治愈或好转占99.73%。结论:河南省JEV-L预防接种安全性良好,需关注过敏性休克、脑炎等严重异常反应的发生。
Abstract:
Aim: To analyze the characteristics of adverse reactions for live attenuated Japanese encephalitis vaccine(JEV-L)in Henan Province from 2011 to 2016, in order to evaluate the immunization safety related to JEV-L.Methods: The adverse reaction data and vaccination doses of JEV-L in Henan Province from 2011 to 2016 were collected through the China Information Management System for Immunization Programming. The descriptive methodology was used for data analysis.Results: A total of 5 236 cases with adverse reactions were reported in Henan Province from 2011 to 2016, the annual average reported incidence rate was 25.74 per 100 000 doses. Among all cases, 5 126 cases was common adverse reaction, accounting for 97.90%, the reported incidence rate was 25.20 per 100 000 doses, and 110 cases was rare adverse reaction, accounting for 2.10%, the reported incidence rate was 0.54 per 100 000 doses. The ratio of male to female was 1.22GA6FA1; 60.06% cases occurred under 1 years old; most of cases were reported from July to September; and the reported cases were mainly concentrated in Luoyang, Zhengzhou and Zhoukou.Most cases occurred after the first dose and within 1 d after vaccination. The symptoms of common vaccine reactions were fever, local swelling and indurations, the main diagnosis of rare vaccine reactions were anaphylactic disorders.Anaphylactic shock and encephalitis were reported in rare adverse reaction. 99.73% cases were recovered or got better.Conclusion: The JEV-L vaccine safety is good in Henan Province. The surveillance should focus on the anaphylactic shock and encephalitis and other serious rare adverse reaction.

参考文献/References:

[1] 李兰娟,任红.传染病学[M].8版.北京:人民卫生出版社,2013:86
[2] 卫生部,国家食品药品监督管理局.全国疑似预防接种异常反应监测方案[S]. 北京:国家食品药品监督管理总局,2010.
[3] 卫生部.扩大国家免疫规划实施方案[S].北京:中华人民共和国国家卫生和计划生育委员会,2007.
[4] 叶家楷,李克莉,许涤沙,等.中国2013年疑似预防接种异常反应信息管理系统数据分析[J].中国疫苗和免疫,2015,21(2):121
[5] 叶家楷,李克莉,许涤沙,等.中国2014年疑似预防接种异常反应信息管理系统监测数据分析[J].中国疫苗和免疫,2016,22(2):125
[6] 龚琼宇,陈玉娟,胡筱莛,等.云南省2015年疑似预防接种异常反应监测分析[J].中国疫苗和免疫,2016,22(5):571
[7] 刘宇,赵占杰,谢莘,等. 广东省2005～2014年疑似预防接种异常反应监测数据分析[J].中国疫苗和免疫,2016,22(2):202
[8] 叶莹,史鲁斌,李军,等.河南省2009至2014年疑似预防接种异常反应监测分析[J].郑州大学学报(医学版),2016,51(2):258
[9] 刘大卫,郭飚,曹玲生,等.流行性乙型脑炎减毒活疫苗和灭活疫苗上市后预防接种安全性的比较分析[J].中国疫苗和免疫,2008,14(4):292
[10]Plotkin S.疫苗学[M].北京:人民卫生出版社,2011:26
[11]THOON KC,SOH SB,LIEW WK,et al.Active surveillance of adverse events following childhood immunization in Singapore[J].Vaccine,2014,32(39):5000
[12]SANCHAYAN K,FERNANDOPULLE R,AMARASINGHE A,et al.Safety of live attenuated Japanese encephalitis vaccine given at the age of 9 months in National Immunisation Programme of Sri Lanka[J].Ceylon Med J,2016,61(3):99
[13]WANG Y,DONG D,CHENG G,et al.Post-marketing surveillance of live-attenuated Japanese encephalitis vaccine safety in China[J].Vaccine,2014,32(44):5875

备注/Memo

备注/Memo:
*河南省科技厅科技发展计划项目 162400410289
△男,1986年2月生,硕士,医师,研究方向:免疫规划及疫苗可预防疾病的流行病学,E-mail:shilubin3386@163.com
更新日期/Last Update: 2017-11-20